AustralianSuper Pty Ltd

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1694164 MELBOURNE, C3

Position in ALNY

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$1,589,168

-$320,744 QoQ

Shares Held

4,803

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AustralianSuper Pty Ltd holds $113,500,409 across 5 Biotechnology names. ALNY ranks #4 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,137,143	$107,027,899
2	INSM	INSMED Inc	11,670	$1,908,278
3	ARGX	Argenx SE	2,220	$1,621,155
4	ALNY	Alnylam Pharmaceuticals, Inc. This page	4,803	$1,589,168
5	VRTX	Vertex Pharmaceuticals Inc / Ma	3,032	$1,353,909

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,589,168	4,803	0.0%	Shares	Sole	2026-05-07
2025-12-31	$1,909,912	4,803	-16.4%	Shares	Sole	2026-02-05
2025-09-30	$2,618,352	5,742	+36.1%	Shares	Sole	2025-11-12
2025-06-30	$1,375,447	4,218	0.0%	Shares	Sole	2025-08-01
2025-03-31	$1,138,944	4,218	0.0%	Shares	Sole	2025-05-05
2024-12-31	$992,537	4,218	+15.7%	Shares	Sole	2025-01-30
2024-09-30	$1,002,484	3,645	—	Shares	Sole	2024-10-28
No filing history on record for this holder in this stock.